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Abstract
This analysis was performed as part of the Truckers and Turnover Project and 
was supported by the study firm, the Roadway Safety Institute (the US DOT 
Region 5 University Transportation Center, based at the University of 
Minnesota, Twin Cities), and the University of Minnesota, Morris. This specific 
research is part of a larger project involving multiple faculty and student co-
authors. 
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Table 2: Sensitivity, Specificity, Positive Predictive Value, 
and Negative Predictive Value
W/O
Certification 
status
W/ 
Certification 
status
Sensitivity 74% 71%
Specificity 84% 90%
Positive PredictiveValue 77% 83%
Negative PredictiveValue 81% 81%
The Effectiveness of the Commercial Driver Medical Examination in Screening for 
Hypertension
The Truckers & Turnover Project received approximately 4000 optical scans of 
CDME records and University of Minnesota Morris students typed the data into 
Excel spreadsheets. There are three ways to determine whether the medical 
examiner correctly identified drivers with hypertension. First, in the health 
history section of the CDME, the drivers self report whether they have a history 
of hypertension and whether they are taking medication for hypertension. 
Second, a blood pressure measurement is taken during the examination. Third, 
for drivers who are certified to drive for less time than the standard of 2 years, 
the medical examiner leaves a comment on why a reduced status was given, and 
hypertension may be noted. We used International Classification of Diseases 
(Ninth Revision, ICD9) diagnosis codes in the medical insurance claims data and 
Clinical Classification Software to determine whether the driver had a claim 
including a diagnosis of hypertension.
While working with CDME data that should have contained one line per driver, 
we found 51 drivers had two CDMEs. We first dropped exams for which the 
driver’s certification status was missing, resulting in 6 duplicate drivers being 
dropped. For the remaining 45 drivers, we dropped older exams. Because the 
incidence of hypertension only changes between exams for less than 10 duplicate 
drivers, this should not have a substantive impact on the analysis results. We then 
merged CDME and claims data, giving us a dataset containing 3,073 drivers who 
have both CDME and medical insurance records. Finally, we rolled up the 
medical insurance data, which comes in the form of multiple lines per claim, to 
one line per driver, including ICD9 diagnosis codes.
Table 1: Incidence of Hypertension in CDME and 
Medical Records
CDME 
Screening N
Medical Claims data
Positive Negative
Positive 1,268 979 289
Negative 1,805 341 1,464
Total 3,073 1,320 1,753
The Commercial Driver Medical Examination (CDME) is used to assess the 
medical fitness of a driver to safely operate a commercial motor vehicle. 
Hypertension is a disease that has been shown in prior research to cause reduced 
driving safety performance when not properly managed, and it is therefore 
important that medical examiners be able to consistently identify it in drivers. 
However, the CDME has historically been ineffective at screening drivers with 
safety-related diseases. For example, a report from the US Government 
Accountability Office showed the existence of a substantial number of drivers 
who were deemed eligible by the federal government for full disability benefits 
and yet also passed their CDME’s. To address these issues, the Federal Motor 
Carrier Safety Administration (FMCSA) instituted the Medical Examiner 
Registry and mandatory training programs for examiners. This project uses data 
from before these reforms to establish a baseline for comparison to the new 
version of the CDME. We compare hypertension as captured in CDME records 
to hypertension as captured in medical insurance claims data on the same drivers. 
Our initial results indicate that of the 1,320 drivers who were determined from 
the insurance data to have hypertension, medical examiners were able to 
correctly identify 74% of them as having the condition. This suggests that while 
the CDME was moderately successful in screening for hypertension even before 
the reforms, there was room for improvement. 
Both the FMCSA and the Medical Review Board have recommended screening 
for hypertension as a safety-related medical disease during the CDME, but the 
CDME has historically been relatively ineffective at screening drivers with 
safety-related diseases. However, our findings suggest that the CDME was 
moderately successful in screening for hypertension even before the FMCSA’s 
reforms, although there is room for improvement.
Future research is needed to examine the effectiveness of the CDME in 
screening for hypertension after the initiation of the new Medical Examiner 
Registry. The results of this study serve as a benchmark for future work of this 
type.
Further studies of this nature are needed. The screening effectiveness of the 
CDME may vary across medical conditions, and it is important for the safety of 
the public highways that examiners appropriately identify and certify drivers 
based on their actual medical fitness to operate commercial motor vehicles.
We analyzed the data by comparing the incidence of hypertension as captured in 
the CDME to the incidence as captured in medical insurance claims for the same 
drivers. During the period that our data come from, hypertension was defined 
as persistently having systolic blood pressure ≥ 140 or diastolic blood pressure ≥ 
90.
Using our indicators of hypertension in the CDME and medical insurance 
claims, we calculated the sensitivity, specificity, positive predictive value, and 
negative predictive value of the CDME for screening for hypertension. These 
four statistics are defined as:
• Sensitivity: percent of actual positives identified;
• Specificity: percent of actual negatives identified;
• Positive predictive value: given a positive screening, the percent chance the 
screening is correct;
• Negative predictive value: given a negative screening, the percent chance the 
screening is correct.
In addition, we repeated the analysis while examining the certification status of 
drivers who were identified as having hypertension in the CDME; drivers may 
be certified for up to 2 years, but examiners may give a reduced certification 
period to drivers whose health does not preclude safe driving but requires close 
monitoring. Thus, we analyze not only how often hypertension is caught in the 
CDME, but how often medical examiners take action to make sure drivers with 
the condition remain fit to drive.
Positive predictive value is the probability the driver has the disease given the 
CDME screening is positive. The positive predictive value is 77%. This value 
may be lower than what one would expect; however, we speculate that there 
are two reasons why this is substantially below 100%: (1) a substantial portion 
of drivers who have hypertension don’t have a hypertension-related medical 
insurance claim, and (2) a driver’s blood pressure may rise above its typical 
level during the CDME.
When we repeat the analysis while examining whether drivers who are 
identified as having hypertension in the CDME are given a reduced 
certification status, we expect that the sensitivity will fall since both 
identifying that the driver has hypertension and giving the driver a reduced 
certification status is a more stringent standard. However, the sensitivity falls 
only slightly, from 74% to 71%, suggesting that when examiners are aware 
that the driver has hypertension, they almost always require more frequent 
monitoring of the driver’s health.
Table 1 shows that the number of positives in the medical claims data (1,320) is 
only slightly larger than the number of positives in the CDME (1,268), 
suggesting that the CDME is at least moderately effective at screening for 
hypertension. 
This is confirmed by the results in Table 2. Sensitivity is the probability that the 
CDME screening will be positive given that the driver has the disease. Of the 
1,320 drivers who were indicated to have hypertension in the claims data, 979 
were identified in the CDME, resulting in a sensitivity of 74%. This provides 
evidence that the CDME is able to screen for hypertension with moderate 
success.
